资讯

PipelineReview.com12 小时
VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at ...
New data show AAV-delivered antibody fragments targeting oxidized phosphatidylcholines (PC-OxPL), a species of oxidized phospholipids, thereby neutralizing ...